Provided by Tiger Trade Technology Pte. Ltd.

Lineage

34.80
+0.42001.22%
Post-market: 34.800.00000.00%16:20 EST
Volume:1.29M
Turnover:45.21M
Market Cap:7.94B
PE:-43.82
High:35.60
Open:34.36
Low:34.36
Close:34.38
52wk High:62.30
52wk Low:32.46
Shares:228.29M
Float Shares:57.64M
Volume Ratio:0.76
T/O Rate:2.24%
Dividend:2.11
Dividend Rate:6.07%
EPS(TTM):-0.7941
EPS(LYR):-3.6963
ROE:-2.04%
ROA:0.73%
PB:0.95
PE(LYR):-9.41

Loading ...

Kevin Patrick Marchetti, Co-Executive Chairman, Reports Acquisition of Common Shares of Lineage Inc

Reuters
·
Aug 12

BofA Securities Downgrades Lineage to Underperform From Neutral

MT Newswires Live
·
Aug 11

Lineage Q2 Adjusted FFO, Revenue Increase; 2025 AFFO Guidance Lowered

MT Newswires Live
·
Aug 06

Lineage Q2 EPS $(0.03) Beats $(0.07) Estimate, Sales $1.350B Beat $1.331B Estimate

Benzinga
·
Aug 06

GUIDANCE: (LINE) Lineage Expects 2025 Adjusted FFO $3.20 - $3.40 a Share, vs. FactSet Est of $3.40

MT Newswires Live
·
Aug 06

Earnings Flash (LINE) Lineage Posts Q2 Adjusted FFO $0.81 a Share, vs. FactSet Est of $0.76

MT Newswires Live
·
Aug 06

Lineage Inc. Reports Q2 2025 Revenue Growth of 0.9%, GAAP Net Loss of $7 Million, Adjusted EBITDA Down 2.4%

Reuters
·
Aug 06

Lineage, Inc. Reports Second-Quarter 2025 Financial Results

THOMSON REUTERS
·
Aug 06

Lineage Inc Outlook 2025 Adj Ffo per Share of $3.20 to $3.40

THOMSON REUTERS
·
Aug 06

Lineage Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Aug 04

VALUE LINE, INC. ANNOUNCES HIGHER FISCAL YEAR 2025 EARNINGS

GlobeNewswire
·
Jul 30

Lineage Is Maintained at Neutral by UBS

Dow Jones
·
Jul 24

UBS Adjusts Price Target on Lineage to $45 From $49, Maintains Neutral Rating

MT Newswires Live
·
Jul 23

Lineage Is Maintained at Overweight by Barclays

Dow Jones
·
Jul 21

Lineage Cut to Sector Weight From Overweight by Keybanc

Dow Jones
·
Jul 01

KeyBanc Downgrades Lineage to Sector Weight From Overweight on Valuation, Lower Growth Outlook, Removes $84 Price Target

MT Newswires Live
·
Jul 01

Lineage Inc. to Announce Second-Quarter 2025 Financial Results

Reuters
·
Jul 01

Lineage Faces Downside Risks to H2 Recovery Amid Tariff Headwinds, Morgan Stanley Says

MT Newswires Live
·
Jun 23

Lineage Cell Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 23

Lineage Cut to Underweight From Neutral by JP Morgan

Dow Jones
·
Jun 23